Shares of Tivity Health Inc (NASDAQ:TVTY) have earned a consensus recommendation of “Buy” from the twelve research firms that are currently covering the company, MarketBeat.com reports. Two research analysts have rated the stock with a sell recommendation, one has given a hold recommendation and eight have assigned a buy recommendation to the company. The average twelve-month price objective among analysts that have updated their coverage on the stock in the last year is $30.22.
Several equities analysts have recently issued reports on the stock. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $40.00 price target (down previously from $45.00) on shares of Tivity Health in a research note on Tuesday. Credit Suisse Group assumed coverage on shares of Tivity Health in a research note on Friday, January 3rd. They set a “neutral” rating and a $22.00 price target for the company. Barrington Research reaffirmed a “buy” rating and set a $38.00 price target on shares of Tivity Health in a research note on Monday, December 23rd. BidaskClub downgraded shares of Tivity Health from a “strong-buy” rating to a “buy” rating in a research note on Thursday. Finally, ValuEngine downgraded shares of Tivity Health from a “hold” rating to a “sell” rating in a research note on Thursday, January 16th.
Tivity Health stock traded down $0.67 during mid-day trading on Tuesday, reaching $23.91. The company had a trading volume of 15,001 shares, compared to its average volume of 696,412. Tivity Health has a fifty-two week low of $14.84 and a fifty-two week high of $26.07. The company has a current ratio of 0.94, a quick ratio of 0.78 and a debt-to-equity ratio of 1.96. The company has a market cap of $1.19 billion, a P/E ratio of 16.71, a P/E/G ratio of 1.11 and a beta of 1.16. The business has a fifty day simple moving average of $21.51 and a 200 day simple moving average of $18.64.
A number of hedge funds and other institutional investors have recently made changes to their positions in the stock. HG Vora Capital Management LLC grew its holdings in shares of Tivity Health by 850.0% during the second quarter. HG Vora Capital Management LLC now owns 4,750,000 shares of the company’s stock valued at $78,090,000 after buying an additional 4,250,000 shares during the last quarter. Morgan Stanley raised its position in Tivity Health by 300.4% in the second quarter. Morgan Stanley now owns 2,771,427 shares of the company’s stock worth $45,562,000 after acquiring an additional 2,079,309 shares during the period. Bank of America Corp DE raised its position in Tivity Health by 300.0% in the second quarter. Bank of America Corp DE now owns 1,653,998 shares of the company’s stock worth $27,193,000 after acquiring an additional 1,240,536 shares during the period. Parametric Portfolio Associates LLC raised its position in Tivity Health by 91.2% in the third quarter. Parametric Portfolio Associates LLC now owns 783,794 shares of the company’s stock worth $13,035,000 after acquiring an additional 373,782 shares during the period. Finally, BlackRock Inc. raised its position in Tivity Health by 4.8% in the second quarter. BlackRock Inc. now owns 7,343,863 shares of the company’s stock worth $120,732,000 after acquiring an additional 337,571 shares during the period.
Tivity Health Company Profile
Tivity Health, Inc provides fitness and health improvement programs in the United States. The company offers SilverSneakers senior fitness program to the members of Medicare advantage, Medicare supplement; and Prime fitness, a fitness facility access program through commercial health plans and employers.
See Also: Monthly Dividend Stocks
Receive News & Ratings for Tivity Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tivity Health and related companies with MarketBeat.com's FREE daily email newsletter.